Rhabdomyosarcoma: Clinical Trials

18 trials for Rhabdomyosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 4 recruiting, 2 active not recruiting, 1 not yet recruiting. 18 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 318Completed 10, Recruiting 4, Active not recruiting 2, Not yet recruiting 1, Terminated 1
Phase 21Not yet recruiting 1

Follow Rhabdomyosarcoma: new trials by email Literature Review of Rhabdomyosarcoma trials Research Report on Rhabdomyosarcoma

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Rhabdomyosarcoma
Phase 3RecruitingChildren's Oncology Group3422026-07-142026-08-25
Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms
Right Arm treated with Active Re-Q Pro-Longevity Serum and Intense Pulsed Light Therapy, Left Arm treated with vehicle serum and Intense Pulsed Light Therapy - Photodamaged Skin
Phase 2 / Phase 3Not yet recruitingGoldman, Butterwick, Fitzpatrick and Groff202026-07-102026-07-07
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Biopsy Procedure, Bone Scan, Computed Tomography - Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma
Phase 3RecruitingChildren's Oncology Group2052022-08-042026-08-25
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma
Phase 3Active not recruitingChildren's Oncology Group1132021-09-142026-07-30
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
dinutuximab beta - Bone Sarcoma, Embryonal Rhabdomyosarcoma
Phase 3RecruitingN.N. Petrov National Medical Research Center of Oncology402021-05-202024-11-01
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
VAC,VAC/VII,CAV/IE - Rhabdomyosarcoma, Pediatric Cancer
Phase 3RecruitingYizhuo Zhang3002017-01-302025-02-20
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
Cyclophosphamide, Dactinomycin, Irinotecan Hydrochloride - Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma
Phase 3Active not recruitingNational Cancer Institute (NCI)3252016-06-012026-10-01
Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
trofosfamide, idarubicin, etoposide - Soft Tissue Sarcoma
Phase 3CompletedUniversity Hospital Tuebingen1952009-07-012022-11-08
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Cyclophosphamide, Dactinomycin, Irinotecan Hydrochloride - Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma
Phase 3CompletedChildren's Oncology Group4812006-12-262023-01-31
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
dactinomycin, cyclophosphamide, doxorubicin hydrochloride - Sarcoma
Phase 3CompletedChildren's Oncology Group1092006-07-012020-01-29
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
conventional surgery, dactinomycin, cyclophosphamide - Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma
Phase 3CompletedChildren's Oncology Group3902004-09-042021-11-19
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
pegfilgrastim, doxorubicin hydrochloride, ifosfamide - Sarcoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC4552003-04-012014-10-27
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
dactinomycin, vincristine sulfate, cyclophosphamide - Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma
Phase 3CompletedChildren's Oncology Group7022002-09-012013-06-17
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
doxorubicin hydrochloride, ifosfamide - Sarcoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC7801998-01-012012-01-20
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
dactinomycin, filgrastim, sargramostim - Sarcoma
Phase 3CompletedChildren's Oncology Group4831997-08-012014-02-14
Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma
doxorubicin hydrochloride, etoposide, ifosfamide - Sarcoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC3401997-07-012013-09-17
Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide - Rhabdomyosarcoma, Malignant Soft Tissue
Phase 3TerminatedGustave Roussy, Cancer Campus, Grand Paris4001995-07-012005-09-13
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
filgrastim, doxorubicin hydrochloride, ifosfamide - Endometrial Cancer, Kidney Cancer
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC3501995-02-012014-08-08

Narrower conditions

Sarcoma (9)  ·  Sarcoma, Synovial (5)  ·  Fibrosarcoma (4)  ·  Hemangiosarcoma (4)  ·  Histiocytoma, Malignant Fibrous (4)  ·  Leiomyosarcoma (4)  ·  Liposarcoma (4)  ·  Malignant mesenchymal tumor (4)  ·  Neurofibrosarcoma (4)  ·  Rhabdomyosarcoma, Alveolar (4)  ·  Rhabdomyosarcoma, Embryonal (4)  ·  Hemangiopericytoma, Malignant (2)  ·  Bone Neoplasms (1)  ·  Endometrial Neoplasms (1)

Broader conditions

Myosarcoma (18)  ·  Neoplasms by Histologic Type (18)  ·  Neoplasms, Connective and Soft Tissue (18)  ·  Neoplasms, Muscle Tissue (18)  ·  Neoplasms (17)  ·  Sarcoma (9)  ·  Neoplasms, Connective Tissue (5)  ·  Histiocytoma (4)  ·  Neoplasms, Adipose Tissue (4)  ·  Neoplasms, Fibrous Tissue (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Neoplasms, Vascular Tissue (4)  ·  Nerve Sheath Neoplasms (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)

Interventions

Radiotherapy (11)  ·  Vincristine (10)  ·  Cyclophosphamide (9)  ·  Dactinomycin (9)  ·  Radiation (7)  ·  Ifosfamide (6)  ·  Doxorubicin (5)  ·  Etoposide (4)  ·  Filgrastim (4)  ·  Irinotecan (4)  ·  Biopsy (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Vinorelbine (3)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Specimen Handling (2)

Sponsors

Children's Oncology Group (8)  ·  European Organisation for Research and Treatment of Cancer - EORTC (4)  ·  Goldman, Butterwick, Fitzpatrick and Groff (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  N.N. Petrov National Medical Research Center of Oncology (1)  ·  National Cancer Institute (NCI) (1)  ·  University Hospital Tuebingen (1)  ·  Yizhuo Zhang (1)

Countries

Canada (10)  ·  United States (10)  ·  Australia (7)  ·  Switzerland (7)  ·  Puerto Rico (6)  ·  Germany (5)  ·  New Zealand (5)  ·  France (4)  ·  Netherlands (4)  ·  Austria (3)  ·  Belgium (3)  ·  Denmark (3)  ·  Slovakia (3)  ·  Spain (3)  ·  United Kingdom (3)

Top investigators

Abha A Gupta (1)  ·  Brenda Weigel, MD (1)  ·  Carola A Arndt, MD (1)  ·  Carola Arndt (1)  ·  Christine M Heske (1)  ·  David Walterhouse, MD (1)  ·  Douglas S Hawkins (1)  ·  Ewa Koscielniak, MD (1)  ·  Ian R. Judson, MA, MD, FRCP (1)  ·  Josephine H Haduong (1)  ·  Monika Sparber Sauer, MD (1)  ·  Paul C. Lorigan, MD (1)  ·  Penella J. Woll, MD, PhD (1)

Results publications

PMID 38603649, PMID 17634494, PMID 18286501, PMID 20434400, PMID 21357783, PMID 22104356, PMID 22954508, PMID 24618336, PMID 24747207, PMID 29450452, PMID 30091945, PMID 31174239, PMID 34666214, PMID 35829629, PMID 38936378, PMID 39687431, PMID 41914453, PMID 42035475

NIH funding

U10CA180886 (5), U10CA098543 (3)